› Forums › General Melanoma Community › Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
- This topic is empty.
- Post
-
- May 20, 2014 at 5:41 pm
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody
- You must be logged in to reply to this topic.